Pei Ouyang

Pei Ouyang

Auto-generated profile, based on publicly available information

Pei Ouyang

National Children’s Medical Center, Children’s Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan SANS Neuroscience Center, Fudan University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2025 in Science
Verified
Journal Article
Closed access
JWJingying Wu
Jingying Wu
YWYafei Wang
Yafei Wang
XLXiaoyu Li
Xiaoyu Li
POPei Ouyang
Pei Ouyang
YCYuanyuan Cai
Yuanyuan Cai
BPBo Peng
Bo Peng
Colony-stimulating factor 1 receptor ( CSF1R ) is primarily expressed in microglia. Its monoallelic mutation causes CSF1R-associated microgliopathy (CAMP), a major form of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and a fatal neurological disease without clinical cure. We developed mouse models harboring human hotspot mutations of CAMP and replaced CSF1R-deficient microglia with CSF1R-normal cells through microglia replacement by bone marrow transplantation (Mr BMT), which attenuated pathology in mice. We further demonstrated that, in the context of CSF1R deficiency, traditional bone marrow transplantation (tBMT) in ALSP functions similarly to Mr BMT, efficiently replacing microglia and reducing disease progression. We then replaced CSF1R-deficient microglia in eight patients by tBMT. The disease progression was halted during the 24-month follow-up. Together, microglia replacement corrects pathogenic mutations and halts disease progression in mice and humans.

16 October 2026 in eLife
Verified
Journal Article
Open access
XLXiaoyu Li
Xiaoyu Li
YLYuxin Li
Yuxin Li
YCYue Cao
Yue Cao
NHNiewen Hu
Niewen Hu
BYBaozhi Yang
Baozhi Yang
Yanxia RaoYanxia Rao
Yanxia Rao
In situ glia-to-neuron conversion induced by a single transcription factor is a promising regenerative strategy for treating central nervous system injuries and neurodegenerative diseases. Previous studies reported that NeuroD1 can induce microglia-to-neuron cross-lineage conversion and improve recovery after brain injury. However, these findings remain controversial. To examine the ability of NeuroD1 in inducing microglia-to-neuron conversion, we employed virus-free genetic lineage tracing systems in mice to specifically induce NeuroD1 expression in microglia and track the cell fate of NeuroD1-expressing cells at multiple timepoints. Meanwhile, we longitudinally monitored NeuroD1-expressing microglia via two-photon imaging and characterized their transcriptional profile by single-cell RNA sequencing. All observations across these methods revealed that NeuroD1-expressing cells retained their microglia identity and cannot convert into neurons, under either physiological or injury conditions. Instead, sustained expression of NeuroD1 induced microglial apoptosis in vivo. Collectively, our findings provide strong evidence that NeuroD1 is not sufficient to induce microglia-to-neuron conversion. This study further highlights the importance of rigorous lineage tracing and cell fate mapping strategies for validating in situ glia-to-neuron conversion.